Atrium Innovations clinical trials
Acquired by Nestlé S.A.
The registry lists 3 studies whose lead sponsor is Atrium Innovations. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 12, 2021.
Registry sponsor names on this page
- Atrium Innovations3 studies
Something wrong with this grouping? Tell us on the Nestlé S.A. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Nestlé S.A. studies →
- Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial OvergrowthWithdrawnNCT03420976Early Phase 1
Sponsor listed in the registry: Atrium Innovations · Atrium Innovations — acquired company within the Nestlé S.A. group
- Multi-Center Study Evaluating the Efficacy of Wobenzym(R)N in Treating Knee OsteoarthritisWithdrawnNCT00974428Phase 2/3
Sponsor listed in the registry: Atrium Innovations · Atrium Innovations — acquired company within the Nestlé S.A. group
- The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in AdultsCompletedNCT02088411Phase 2
Sponsor listed in the registry: Atrium Innovations · Atrium Innovations — acquired company within the Nestlé S.A. group